Hana Licenses Zensana To Par, Focuses On Oncology Pipeline Aug. 2, 2007 By Jim Shrine Hana Biosciences Inc., which earlier this year withdrew a new drug application filing for the antiemetic agent Zensana, licensed the product to Par Pharmaceutical Cos. Inc. (BioWorld Today)Read More
Financings roundup: Covidien tells shareholders to use caution related to mini-tender offer Aug. 2, 2007
RSS